A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2002
11/06/2002	CN1378539A Thiocarbamic acid derivatives
11/06/2002	CN1378537A 嘧啶衍生物 Pyrimidine derivatives
11/06/2002	CN1378532A Substituted 1,5-dihydropyrrol-2-on derivatives as NMDA receptor antagonists for treatment of pain
11/06/2002	CN1378531A Substituted pyrolidine-2,3,4-trion-3-oxime derivatives useful as NMDA receptor antagonists
11/06/2002	CN1378528A Use of carbonylamino derivatives against CNS disorders
11/06/2002	CN1378459A Treatment of auto immune diseases with antagonists which bind to B cell surface markers
11/06/2002	CN1377961A Ring structure ribo-enzyme and deoxy-ribozyme and their use
11/06/2002	CN1377879A New alpha-amino acid sulfuryl compounds, its preparing method and medicinal composition containing them
11/06/2002	CN1377698A Nano woman's cleaning and nursing aloe lotion and its preparing method
11/06/2002	CN1377696A Chinese herbal medicine preparation for curing viral hepatitis and its preapring method
11/06/2002	CN1377680A Process for preparing broad spectrum anti-virus medicine and its use
11/06/2002	CN1377663A Chinese herbal medicine capsule for curing tuberculosis and its preparing method
11/06/2002	CN1377661A Therapeutic liquid for common cold and rhinitis and its preparing method and use
11/06/2002	CN1377659A Rash-eliminating and psoriasis-treating medicine liquid
11/06/2002	CN1377648A Imiquimod or its derivative liposome for local skin and its preparing method and use
11/06/2002	CN1377637A Herbal pigment and perfume for cosmetics
11/06/2002	CN1093861C 1-methylcarbapenem derivatives
11/06/2002	CN1093852C 维生素ｄ酰胺衍生物 Amide derivatives of vitamin d
11/05/2002	US6476209 Polynucleotides, materials incorporating them, and methods for using them
11/05/2002	US6476201 Methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines
11/05/2002	US6476197 Polypeptides having interferon-γ inducing activity
11/05/2002	US6476195 Secreted protein HNFGF20
11/05/2002	US6476193 NLK1 protein and NLK1 protein complexes
11/05/2002	US6476067 N-formyl hydroxylamine derivatives as antibacterial agents
11/05/2002	US6476062 Chemokine receptor antagonists
11/05/2002	US6476053 Mycobacterial inhibitors
11/05/2002	US6476036 Sodium salt of 3-(4-cinnamyl-1-piperazinyl)-imino-methyl rifamycin SV
11/05/2002	US6476028 Compounds and methods
11/05/2002	US6476025 Phenylphennanthridines with PDE-IV inhibiting activity
11/05/2002	US6476020 Imidazo-benzazepine compounds, their compositions and uses
11/05/2002	US6476018 Fused imidazole derivatives as multidrug resistance modulators
11/05/2002	US6476015 N-thiolated β-lactam antibiotics
11/05/2002	US6476000 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
11/05/2002	US6475997 Methods of stimulating phagocytosis
11/05/2002	US6475996 Use of a vector expressing DNA polymerase β as medicine
11/05/2002	US6475992 Methods of and compositions for potentiating the action of agents active on cell wall sites of the susceptible bacteria
11/05/2002	US6475986 Uses of THANK, a TNF homologue that activates apoptosis
11/05/2002	US6475780 Alphavirus vectors for paramyxovirus vaccines
11/05/2002	US6475718 Genetically engineered eukaryotic cell; for prevention of viral infections; viricides
11/05/2002	US6475518 Methods and compositions for treatment of disorders associated with chlamydia and similar bacterial infection
11/05/2002	US6475493 Controlled release pellet formulation
11/05/2002	US6475491 Treatment of HIV and other viral infections using combinatorial therapy
11/05/2002	US6475480 Use of adenoviral E4 reading frames to improve expression of a gene of interest
11/05/2002	CA2324467C Formulations for protection of peg-interferon alpha conjugates
11/05/2002	CA2205366C Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same
11/05/2002	CA2038029C 1-alkyl-, 1-alkenyl- and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds, a process and intermediates for their preparation and theeir use as medicaments
11/05/2002	CA2037779C Antibiotic ge 2270 factors b1, b2, c1, c2, d1, d2, e and t
11/04/2002	WO2004001058A2 Transcription factor modulating compounds and methods of use thereof
10/2002
10/31/2002	WO2002086156A2 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
10/31/2002	WO2002086105A1 Delivery of polynucleotide agents to the central nervous sysstem
10/31/2002	WO2002086101A2 Core-glycosylated hcv envelope proteins
10/31/2002	WO2002086100A2 Expression of core-glycosylated hcv envelope proteins in yeast
10/31/2002	WO2002086090A2 Identification of essential genes of aspegillus fumigatus and methods of use
10/31/2002	WO2002086087A2 Cytokine protein family
10/31/2002	WO2002086078A2 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
10/31/2002	WO2002086069A2 Secreted proteins
10/31/2002	WO2002085945A2 Vhh single heavy chain antibody and a method for its preparation in a mammal
10/31/2002	WO2002085944A2 Single chain camelid vhh antibodies, method for their production in a mammal and their uses
10/31/2002	WO2002085940A2 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002	WO2002085937A2 Inflammation-specific peptides and the uses thereof
10/31/2002	WO2002085934A2 Antibacterial peptides, compositions containing same and uses thereof
10/31/2002	WO2002085932A2 Constructs and methods for expression of recombinant hcv envelope proteins
10/31/2002	WO2002085930A2 Immunomodulating agents from parasitic worms and method for isolation thereof
10/31/2002	WO2002085928A2 Modified cyclosporine which can be used as a pro-drug and use thereof
10/31/2002	WO2002085925A2 Melanocortin receptor ligands
10/31/2002	WO2002085906A2 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002	WO2002085905A1 Novel adenine derivatives
10/31/2002	WO2002085899A1 Heterocyclyldicarbamides as caspase inhibitors
10/31/2002	WO2002085898A1 Clathrate of azithromycin hydrate with 1,2-propyleneglycol, method for the manufacture thereof and pharmaceutical composition comprising same
10/31/2002	WO2002085897A1 Heterocyclic compounds for aging-related and diabetic vascular complications
10/31/2002	WO2002085894A1 Arylindenopyridines with pde inhibiting activity
10/31/2002	WO2002085888A1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same
10/31/2002	WO2002085886A2 Chiral, broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions
10/31/2002	WO2002085869A1 Arylsulfonamides as antiviral agents
10/31/2002	WO2002085867A1 Antibiotics aa-896
10/31/2002	WO2002085865A1 A method for the preparation of oxazolidinones
10/31/2002	WO2002085863A1 Novel compounds of the family of 3-alkyl-(4,5 diphenyl-imidazol-1-yl) and their use as soothing agents
10/31/2002	WO2002085860A1 Pyrazole derivatives for treating hiv
10/31/2002	WO2002085859A1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS
10/31/2002	WO2002085848A2 Synthesis of pancratistatin prodrugs
10/31/2002	WO2002085827A1 Extract from the pods of lupin seeds containing lupeol
10/31/2002	WO2002085447A2 Microprojection array having a beneficial agent containing coating
10/31/2002	WO2002085446A2 Microprojection array immunization patch and method
10/31/2002	WO2002085411A1 Smallpox vaccine
10/31/2002	WO2002085409A2 Methods and compositions for inducing an immune response to an antigen
10/31/2002	WO2002085402A1 Methods and compositions for treating oral and eosophageal lesions
10/31/2002	WO2002085387A2 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent ans their use in the treatment of inflammatory skin conditions
10/31/2002	WO2002085386A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue
10/31/2002	WO2002085385A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa
10/31/2002	WO2002085384A2 Lubricious coatings for substrates
10/31/2002	WO2002085365A1 Tricyclic compounds useful as hiv reverse transcriptase inhibitors
10/31/2002	WO2002085311A2 Hcg formulation
10/31/2002	WO2002085310A2 Antibiotics aa-896
10/31/2002	WO2002085301A2 Indole, azaindole and related heterocyclic amidopiperazine derivatives
10/31/2002	WO2002085299A2 Therapeutic treatments using the direct application of antimicrobial metal compositions
10/31/2002	WO2002085295A2 Methods and compositions for the modulation of biofilm formation
10/31/2002	WO2002085283A2 Vaccine against tuberculosis
10/31/2002	WO2002085113A1 Controlled release particles
10/31/2002	WO2002085093A2 Replikin peptides and uses thereof
10/31/2002	WO2002070499A3 Prodrugs derivatives of the ascorbic acid suitable to the passage of the hematoencephalic barrier

1 ... 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 ... 1798